79.75 +0.87 (1.10%)
ALXN
| Trade ALXN now with |
Stock Details
Last Trade:79.75 Change:+0.87 (1.10%) Prev Close:78.88 Open: 78.75 Days Range:78.20 – 80.08 52 Week Range: 43.78 - 105.00 Volume:897214 P/E: 99.69EPS:0.80
View AllRecent Alerts 02/07/12
Recent Alert on 02/03/12 at 7:50am
Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List
Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List
Goldman Sachs add Alexion Pharmaceuticals (NASDAQ: ALXN) to its Conviction Buy List with a price target of $91 (up from $83), suggesting 17% Upside The firm is calling ALXN "one of the most attractive stories in biotech." Goldman's analyst... Read More
Recent Alert on 02/03/12 at 7:50am
Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List
Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List
Recent Alert on 02/03/12 at 7:50am
Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List
Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List
Recent Alert on 01/24/12 at 10:21am
Oppenheimer Boots Price Target On Alexion (ALXN) Following Asfotase Alfa Review
Oppenheimer Boots Price Target On Alexion (ALXN) Following Asfotase Alfa Review
Recent Alert on 01/23/12 at 2:43pm
Goldman Sachs Lifts Price Target On Alexion Pharmaceuticals (ALXN) to $83
Goldman Sachs Lifts Price Target On Alexion Pharmaceuticals (ALXN) to $83
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/06/12 at 5:43pm
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: Coissac Patrice
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: Coissac Patrice
SEC Filing on 02/06/12 at 5:26pm
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: DUBIN THOMAS I H
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: DUBIN THOMAS I H
SEC Filing on 02/06/12 at 5:19pm
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: Carmichael Clare
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: Carmichael Clare
View AllRecent Blog Posts
Blog Posts on 02/06/12 at 1:20pm
Alexion Pharmaceuticals: No Competition, A Solid Pipeline And Takeover Fever
Alexion Pharmaceuticals: No Competition, A Solid Pipeline And Takeover Fever
Blog Posts on 02/03/12 at 4:09am
Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech
Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech


